Health Corridor is vital for the prosperity and healthy cooperation for China and Pakistan, said Abdul Rehman Khan from the School of Medicine at Zhejiang University in an interview with China Economic Net.
Rehman mentioned China Pakistan Medical Association (CPMA), which was inspired by the concept of China Pakistan Health Corridor and it established to strengthen the medical cooperation between the two countries. I’m always be ready to do something for it,” Rehman showed his determination.
At present, the exchange of scholars between the two countries for further training is a crucial step.
“With the best medical conditions, China always give a helping hand to Pakistan. I hope to learn advanced medical technology in China, serving my motherland in the future,” said Abdul Rehman
Recently, Abdul Rehman Khan published an academic paper on the title of Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma-The Changing Tides in the well-known academic journal Hepatocellular Carcinoma as the first author, under the guidance of his supervisor Professor Xu Xiao, the Associate Dean of School of Medicine, the President of Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine.
As a country with a high incidence of liver cancer, the global cancer report indicates that the number of liver cancer cases in China accounts for 46.7% of the global cases.
Since there are no obvious symptoms of early liver cancer, most patients are already in the middle and late stage when they are first diagnosed, so that lost the opportunity for surgical resection.
Liver cancer is the malignant tumor with the highest mortality rate among adult men under 60 in China.
Especially when hepatocellular carcinoma is combined with portal vein tumor thrombosis (PVTT), the average median survival time is only 2.7 months.
